During these difficult times, the research and medical communities around the world have come together to rapidly produce data on and find treatments for COVID-19. We at the Franklin are proud to be part of these extraordinary efforts. Here is a current summary of our efforts, which we will continue to update:
Protein Production UK based at The Franklin are developing reagents in collaboration with other Franklin structural biologists which will stabilise selected SARS-COV-2 proteins for further analysis including imaging. The selected proteins are key targets for therapeutics and vaccines.
Franklin research leaders: Professors Ray Owens and James Naismith
Collaborators: University of Oxford, Diamond Light Source, The Research Complex at Harwell
As part of an ongoing collaboration with SPT Labtech, we will be using our nationally unique capability and knowledge of the Chameleon system to improve Cryo-EM imaging of SARS-COV-2 components.
Franklin research leaders: Dr Miriam Weckener and Professor James Naismith
Collaborators: SPT Labtech, Diamond Light Source
The Chemistry and structural biology teams are working with partners worldwide to develop novel anti-virals and diagnostics.
Franklin research leaders: Professors Ben Davis and James Naismith
Collaborators: Members of an EU research consortium, University of Oxford
Offering PPE supplies for the NHS:
As part of a Rutherford Appleton Laboratories initiative, our site together have collected 50,000 items of PPE (Personal Protective Equipment) to donate to the Oxford University Hospitals NHS Foundation Trust.